Nexi S.p.A.
Nexi S.p.A. (NEXXY) Financial Performance & Income Statement Overview
Review Nexi S.p.A. (NEXXY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Nexi S.p.A. (NEXXY) Income Statement & Financial Overview
Analyze Nexi S.p.A.’s NEXXY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $3.31B | $2.99B | $3.10B | $0.00 |
| Cost of Revenue | $1.26B | $1.24B | $3.10B | $0.00 |
| Gross Profit | $2.05B | $1.18B | $593000.00 | $0.00 |
| Gross Profit Ratio | $0.62 | $0.40 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $914.17M | $394.60M | $1.71B | $0.00 |
| Operating Expenses | $1.69B | $1.69B | $965.53M | $0.00 |
| Total Costs & Expenses | $2.95B | $2.93B | $4.07B | $0.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $334.89M | $0.00 |
| Depreciation & Amortization | $212.98M | $444.77M | $1.71B | $495.80M |
| EBITDA | $1.65B | $545.52M | $748.31M | $495.80M |
| EBITDA Ratio | $0.50 | $0.18 | $0.24 | $0.00 |
| Operating Income | $354.67M | $100.75M | -$964.93M | $0.00 |
| Operating Income Ratio | $0.11 | $0.03 | -$0.31 | $0.00 |
| Other Income/Expenses (Net) | -$2.83M | -$44.66M | -$61.52M | $0.00 |
| Income Before Tax | $351.84M | $56.09M | -$1.03B | $0.00 |
| Income Before Tax Ratio | $0.11 | $0.02 | -$0.33 | $0.00 |
| Income Tax Expense | $131.30M | $86.19M | $30.79M | $0.00 |
| Net Income | $199.96M | $300.60M | -$1.04B | $0.00 |
| Net Income Ratio | $0.06 | $0.10 | -$0.33 | $0.00 |
| EPS | $0.17 | -$0.02 | -$0.79 | $0.00 |
| Diluted EPS | $0.17 | -$0.02 | -$0.79 | $0.00 |
| Weighted Avg Shares Outstanding | $1.24B | $1.31B | $1.31B | $0.00 |
| Weighted Avg Shares Outstanding (Diluted) | $1.24B | $1.31B | $1.31B | $0.00 |
Over the past four quarters, Nexi S.p.A. demonstrated steady revenue growth, increasing from $0.00 in Q3 2023 to $3.31B in Q4 2024. Operating income reached $354.67M in Q4 2024, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.65B, reflecting operational efficiency. Net income dropped to $199.96M, with EPS at $0.17. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan